With a large number of the unvaccinated pure bloods being sceptical about the mRNA vaccines, the Covid regime has moved to meet consumer demand for a more conventional, non-mRNA vaccine, and here comes the new Novavax, featuring recombinant moth-cell-based nanoparticle technology, surfactant polysorbate 80 and a never-before-approved nanoparticulate adjuvant called Matrix-M, supposedly “free of side effects.”